info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Global Platelet Rich Plasma (PRP) Market will be $985 million by 2030

Global Platelet Rich Plasma (PRP) Market will be $985 million by 2030


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The report "Platelet Rich Plasma" Market by Sample type (Pure PRP, Leukocyte-rich PRP, Pure PRF), Origin (Autologous, Allogenic, and Homologous), Application (Orthopaedic surgery, Cosmetic surgery, General surgery, and neurosurgery) & Region (North America, Europe, Asia Pacific, and Rest of the world)- Global Forecast to 2030. "The Global Platelet Rich Plasma Market share was USD 314 million in 2020. The market is forecasted to reach USD 985 million by 2030, representing a CAGR of 12.12%% throughout the forecasted period. 

 

To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/platelet-rich-plasma-market

 

KEY FACTORS THAT ARE CONTINUOUSLY AUGMENTING THE MARKET GROWTH

The worldwide market is expected to be driven by an increasing number of sports injuries and surgical and cosmetic procedures throughout the forecasted duration time.

 

By Sample Type, the Pure PRP held the highest share in 2020

The Platelet Rich Plasma (PRP) market is segmented into Pure PRP, Leukocyte-rich PRP, and Pure PRF based on Sample type. The Pure PRP segment is projected to grow at the highest rate. The segment's dominance can be primarily attributed to technical improvements in PRP devices, which have led to the rise in usage of pure PRP in various situations, as well as rich platelet content, which are expected to enhance the segment's growth in the coming years. Additionally, the worldwide industry has also benefited from technological improvements such as smart home diagnostic kits.

 

By Origin, the "Autologous" accounted for the maximum share of the market in 2020

The Platelet Rich Plasma (PRP) market is divided into Autologous, Allogenic, and Homologous based on Origin. Autologous held the largest market share in 2020. Autologous platelet-rich plasma (PRP) is a safe, straightforward, and cost-effective treatment that promotes cell proliferation, migration, and angiogenesis. In the treatment of chronic non-healing ulcers, autologous PRP is quite effective. The need for autologous PRP is likely to rise, particularly in developed nations throughout the world.

 

By Application, the "Orthopaedic surgery" accounted for the maximum share of the market in 2020

Based on the Application, the Platelet Rich Plasma market is divided into orthopaedic surgery, Cosmetic surgery, General surgery, and Neurosurgery. Orthopaedic surgery held the largest market share in 2020. During the projection period, the segment is expected to be driven by an increase in the number of orthopaedic procedures.

 

By Region, the "North America" accounted for the maximum share of the market in 2020

Based on Regions, North America is the fastest-growing market. The increase in the incidence of numerous ailments, such as arthritis, well-established healthcare infrastructure, improved regulatory environment, and government assistance, contribute to market expansion in the United States.

 

SOME OF THE NOTABLE PLAYERS ARE PREVAILING IN THE MARKET.

Some of the leading players in the Platelet Rich Plasma Market include SelfDiagnostics, Quidel Corporation, F. Hoffmann-La Roche Ltd., Dickinson and Company, Trinity Biotech plc, Becton, Bionime Corporation, Abbott, ARKRAY, Inc., ACON Laboratories, Inc., and Assure Tech. (Hangzhou) Co., Ltd.

 

Recent Developments: -

  • In February 2021, Atlas Health Medical Group announced that its PRP (Platelet-rich Plasma) Microneedling Facelifts are now available for patients from all across the world.
  • In February 2020, EmCyte finalized the acquisition of Cellmedix Holdings LLC, which comprised all of the organization's assets, including its patented product system, the Intrepid Platelet Concentrator.

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved